AlphaStocks
3.8
Weak

Addus HomeCare Corp (ADUS)

Health Care / Health Care Services

S&P SmallCap 600

$93.83

Scores poorly across most models. Proceed with caution.

Weak

Score based on 4 of 5 models — moderate confidence

#884out of 1127 in Health Care

Is Addus HomeCare Corp a Good Investment in 2026?

Addus HomeCare Corp (ADUS) scores 3.8 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates Addus HomeCare Corp as Strong (7/9). However, the Graham model rates it Caution — 14% above fair value. Addus HomeCare Corp currently trades below its estimated fair value of $134, suggesting potential upside. Addus HomeCare Corp ranks #884 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E18.0ROE9.0Market Cap2B

Estimated Fair Value

$134.4330% below

Fair value above market price. EPS grew 23% year-over-year. P/E of 18x is moderate for this quality level.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

7/9

Buffett

Neutral

Business quality & competitive moat

Graham

Caution

14% above fair value

Lynch

Attractive

PEG 2.3 · Stalwart

Greenblatt

Limited Data

Earnings yield + return on capital

Frequently Asked Questions

Is Addus HomeCare Corp (ADUS) a good investment?
Based on AlphaStocks' composite analysis, Addus HomeCare Corp (ADUS) scores 3.8 out of 10, earning a Weak rating. This score is below average, suggesting caution. Fair value above market price. EPS grew 23% year-over-year. P/E of 18x is moderate for this quality level.
What is Addus HomeCare Corp's Piotroski F-Score?
Addus HomeCare Corp's Piotroski F-Score status is Strong. The raw score is 7/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is ADUS overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $134, ADUS appears undervalued. The stock currently trades 30% below its estimated fair value. Fair value above market price. EPS grew 23% year-over-year. P/E of 18x is moderate for this quality level.
How does ADUS compare to other Health Care stocks?
Addus HomeCare Corp ranks #884 out of 1127 stocks in the Health Care sector, placing it in the top 78% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about ADUS?
AlphaStocks evaluates ADUS using five proven investment models. Piotroski: Strong; Buffett: Neutral; Graham: Caution; Lynch: Attractive. These models are combined into a single composite score of 3.8/10.

Similar Stocks

PARRFTIAZN

Compare ADUS with

ADUS vs PARRADUS vs FTIADUS vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer